J Anxiety Disord. 2008;22(2):310-8. Epub 2007 Mar 12.

Paroxetine reduces social anxiety in individuals with a co-occurring alcohol use disorder.

Book SW, Thomas SE, Randall PK, Randall CL.

Source

Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC 29425, USA. booksw@musc.edu

Abstract

Patients with social anxiety disorder who are seen in clinical practice commonly have additional psychiatric comorbidity, including alcohol use disorders. The first line treatment for social anxiety disorder is selective-serotonin-reuptake-inhibitors (SSRIs), such as paroxetine. However, the efficacy of SSRIs has been determined with studies that excluded alcoholics. Forty two subjects with social anxiety and a co-occurring alcohol use disorder participated in a 16-week, double-blind, placebo-controlled clinical trial to determine the efficacy of paroxetine for social anxiety in patients with co-occurring alcohol problems. Paroxetine was superior to placebo in reducing social anxiety, as measured by the Liebowitz Social Anxiety Scale total and subscale scores and additional measures of social anxiety. This study provides the first evidence-based recommendation for the use of an SSRI to treat social anxiety in this patient population.

PMID:: 17448631; [PubMed - indexed for MEDLINE]
PMCID:: PMC2254554

Free PMC Article

Images from this publication.See all images (1) Free text

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Phobias - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder. [Arch Gen Psychiatry. 2005]
Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder.
Liebowitz MR, Gelenberg AJ, Munjack D. Arch Gen Psychiatry. 2005 Feb; 62(2):190-8.
A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder. [Arch Gen Psychiatry. 2004]
A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder.
Wagner KD, Berard R, Stein MB, Wetherhold E, Carpenter DJ, Perera P, Gee M, Davy K, Machin A. Arch Gen Psychiatry. 2004 Nov; 61(11):1153-62.
What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder? [J Clin Psychiatry. 2006]
What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?
Bandelow B, Baldwin DS, Dolberg OT, Andersen HF, Stein DJ. J Clin Psychiatry. 2006 Sep; 67(9):1428-34.
Review [Efficacy and tolerability of escitalopram in anxiety disorders: a review]. [Encephale. 2008]
Review [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
Pelissolo A. Encephale. 2008 Sep; 34(4):400-8. Epub 2008 Aug 15.
Review Spotlight on paroxetine in psychiatric disorders in adults. [CNS Drugs. 2002]
Review Spotlight on paroxetine in psychiatric disorders in adults.
Wagstaff AJ, Cheer SM, Matheson AJ, Ormrod D, Goa KL. CNS Drugs. 2002; 16(6):425-34.

See reviews... See all...

Cited by 5 PubMed Central articles

Anxiety and Substance Use Disorders: A Review. [Psychiatr Times. 2008]
Anxiety and Substance Use Disorders: A Review.
Smith JP, Book SW. Psychiatr Times. 2008 Oct; 25(10):19-23.
Social anxiety disorder and alcohol use disorder co-morbidity in the National Epidemiologic Survey on Alcohol and Related Conditions. [Psychol Med. 2010]
Social anxiety disorder and alcohol use disorder co-morbidity in the National Epidemiologic Survey on Alcohol and Related Conditions.
Schneier FR, Foose TE, Hasin DS, Heimberg RG, Liu SM, Grant BF, Blanco C. Psychol Med. 2010 Jun; 40(6):977-88.
Combining motivational interviewing with compliance enhancement therapy (MI-CET): development and preliminary evaluation of a new, manual-guided psychosocial adjunct to alcohol-dependence pharmacotherapy. [J Stud Alcohol Drugs. 2010]
Combining motivational interviewing with compliance enhancement therapy (MI-CET): development and preliminary evaluation of a new, manual-guided psychosocial adjunct to alcohol-dependence pharmacotherapy.
Heffner JL, Tran GQ, Johnson CS, Barrett SW, Blom TJ, Thompson RD, Anthenelli RM. J Stud Alcohol Drugs. 2010 Jan; 71(1):61-70.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Paroxetine reduces social anxiety in individuals with a co-occurring alcohol use...
Paroxetine reduces social anxiety in individuals with a co-occurring alcohol use disorder.
J Anxiety Disord. 2008 ;22(2):310-8. Epub 2007 Mar 12 .

PubMed
Nitric oxide synthase partial uncoupling as a key switching mechanism for the NO...
Nitric oxide synthase partial uncoupling as a key switching mechanism for the NO/ONOO- cycle.
Med Hypotheses. 2007 ;69(4):821-5. Epub 2007 Apr 19 .

PubMed
Secrets and lies: Breastfeeding and professional paid work.
Secrets and lies: Breastfeeding and professional paid work.
Soc Sci Med. 2007 Jul ;65(2):393-404. Epub 2007 Apr 19 .

PubMed
Altered expression of TLR homolog RP105 on monocytes hypersensitive to LPS in pa...
Altered expression of TLR homolog RP105 on monocytes hypersensitive to LPS in patients with primary biliary cirrhosis.
J Hepatol. 2007 Sep ;47(3):404-11. Epub 2007 Apr 3 .

PubMed
Blastocystis hominis complicating ulcerative colitis.
Blastocystis hominis complicating ulcerative colitis.
J R Soc Med. 1991 Oct ;84(10):623.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: